Stock WIZP WIZE PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Wize Pharma, Inc. Other OTC

Equities

WIZP

US97751M2070

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cantor Fitzgerald Downgrades Mawson Infrastructure to Neutral From Overweight, Adjusts Price Target to $1 From $12
MT
Cantor Fitzgerald Adjusts Price Target on Mawson Infrastructure Group to $3 From $12, Reiterates Overweight Rating
MT
HC Wainwright Adjusts Price Target on Mawson Infrastructure Group to $3 From $17, Reiterates Buy Rating
MT
Cantor Fitzgerald Assumes Mawson Infrastructure Group at Overweight with $12 Price Target
MT
Cantor Fitzgerald Initiates Coverage on Mawson Infrastructure Group With Overweight Rating, $12 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MIGI Stock
  4. WIZP Stock
  5. News Wize Pharma, Inc.
  6. Analyst Reco.